Akso Health Group cash flow to debt ratio of 1.44K% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Akso Health Group's free cash flow has decreased -24.31% from $1.35M last year to $1.02M, signaling decreasing performance

Akso Health Group's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

Akso Health Group has insufficient data to evaluate this check.

Akso Health Group has negative EBITDA, making leverage ratio unreliable

Interest expense is not separately reported in Akso Health Group's latest filing, so interest coverage cannot be calculated.

Akso Health Group's profit margin has decreased (133.31%) in the last year from -391.78% to -914.06%, signaling decreasing performance

Akso Health Group's short-term assets of $196.12M exceed its short-term liabilities of $13.81M

Akso Health Group's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Akso Health Group's return on equity of -34.14%, is lower than 15.00%, indicating bad performance

Akso Health Group's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Akso Health Group had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Akso Health Group has positive free cash flow, indicating the company generates cash after capital expenditures

Akso Health Group has a free cash flow yield of 0.71%, which is below the 2.00% threshold, indicating limited cash return relative to market value

Akso Health Group's yearly earnings has decreased 1.33K% since last year from $-9.46M to $-134.98M, signaling decreasing performance

Akso Health Group's yearly revenue has increased 512.08% since last year from $2.41M to $14.78M, signaling increasing performance

ROIC -41.79% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Akso Health Group's 3-year revenue CAGR of 35.05% is positive, indicating growing revenue over the past 3 years

Akso Health Group had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance

Akso Health Group had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Akso Health Group has insufficient data to evaluate this check.

Akso Health Group has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Akso Health Group is undervalued relative to its fair value price of 15.56 based on EBITDA multiple model

Akso Health Group has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Akso Health Group is overvalued relative to its fair value price of -3.59 based on Earnings Fair Value model

Akso Health Group has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Akso Health Group has a price-to-book ratio of 1.09x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Akso Health Group has a price-to-sales ratio of 29.01x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue